Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in 1L ES-SCLC

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Special Issue on paediatric oncology

Global trends and inequalities in breast cancer survival and care

Multiple myeloma in a resource constrained setting

Global Coalition for Radiotherapy - How to integrate radiotherapy in cancer control plans

Nab-paclitaxel as first line treatment of gastrointestinal neuroendocrine carcinomas shows efficacious results

Trifluridine/tipiracil and bevacizumab combination gives a prolonged PFS compared to trifluridine/tipiracil monotherapy in mCRC

Pembrolizumab a promising option for MIUC patients after radical surgery